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Abstract
Tinnitus chronically affects between 10–15% of the population but, despite its prevalence, the underlying mechanisms are still not
properly understood. One experimental model involves administration of high doses of sodium salicylate, as this is known to reli-
ably induce tinnitus in both humans and animals. Guinea pigs were implanted with chronic electrocorticography (ECoG) electrode
arrays, with silver-ball electrodes placed on the dura over left and right auditory cortex. Two more electrodes were positioned over
the cerebellum to monitor auditory brainstem responses (ABRs). We recorded resting-state and auditory evoked neural activity
from awake animals before and 2 h following salicylate administration (350 mg/kg; i.p.). Large increases in click-evoked
responses (> 100%) were evident across the whole auditory cortex, despite significant reductions in wave I ABR amplitudes (in
response to 20 kHz tones), which are indicative of auditory nerve activity. In the same animals, significant decreases in 6–10 Hz
spontaneous oscillations (alpha waves) were evident over dorsocaudal auditory cortex. We were also able to demonstrate for the
first time that cortical evoked potentials can be inhibited by a preceding gap in background noise [gap-induced pre-pulse inhibition
(PPI)], in a similar fashion to the gap-induced inhibition of the acoustic startle reflex that is used as a behavioural test for tinnitus.
Furthermore, 2 h following salicylate administration, we observed significant deficits in PPI of cortical responses that were closely
aligned with significant deficits in behavioural responses to the same stimuli. Together, these data are suggestive of neural corre-
lates of tinnitus and oversensitivity to sound (hyperacusis).
Introduction
Sodium salicylate, an analogue of salicylic acid (the active ingredi-
ent of aspirin), reliably induces a tinnitus in both humans and ani-
mals (for a review, see Stolzberg et al., 2012). Tinnitus, deﬁned as
the perception of sound in the absence of an external auditory stim-
ulus, is a symptom that is experienced chronically by 10–15% of
the population (Baguley et al., 2013). The triggering cause in the
majority of cases is likely to be hearing loss as a result of noise
overexposure. Nonetheless, given the reliability of salicylate in
inducing tinnitus compared with the uncertain outcome of noise
exposure, it is a useful research tool for understanding neural
changes associated with the presence of tinnitus.
Salicylate administration at moderate-to-high doses is well known
to have reversible ototoxic effects (Stypulkowski, 1990). This is sug-
gested to occur through a reduction of outer hair cell electromotility
(e.g. Kakehata & Santos-Sacchi, 1996). Central changes have also
been demonstrated in anaesthetized animals, whereby auditory
evoked potentials are enhanced following salicylate administration
(e.g. Lobarinas et al., 2006; Yang et al., 2007). However, Sun et al.
(2009) indicated that anaesthesia may affect salicylate-induced
changes in neural activity. Given that anaesthesia temporarily abol-
ishes consciousness (Alkire et al., 2008) and the presence of tinnitus
by deﬁnition requires conscious perception, it is important to under-
stand the induction of tinnitus by salicylate in awake animals.
Despite its wide use in animal models of tinnitus, there are rela-
tively few studies that have examined neural activity following sali-
cylate in awake animals (Lu et al., 2011; Zhang et al., 2011;
Stolzberg et al., 2013; Sawka & Wei, 2014). Salicylate has been
shown to reduce the size of auditory brainstem responses (ABRs;
Pienkowski & Ulfendahl, 2011), indicative of auditory processing in
the periphery and brainstem, and contrastingly enhance cortical
evoked responses (Yang et al., 2007; Sun et al., 2009; Norena
et al., 2010). Only two studies have examined oscillatory activity in
awake animals following an intervention that causes tinnitus. Norena
et al. (2010) demonstrated a decrease in activity over a fairly broad
frequency range (~ 8–35 Hz) following both salicylate and noise
trauma in guinea pigs (GPs). Subsequently, preliminary data from
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Stolzberg et al. (2013) in rats indicated that salicylate caused
decreases in delta and alpha band activity, as well as an increase in
low gamma activity (~ 20–80 Hz).
Given that changes in oscillatory activity have been proposed as
biomarkers for tinnitus in humans (for a review, see Adjamian
et al., 2009), it is important to further explore these in an animal
model. Here, we recorded electrocorticographic (ECoG) activity
from awake GPs, before and after the administration of salicylate. In
the same animals, we examined resting-state oscillatory activity,
wave I ABRs (which informed us of peripheral activity), gap detec-
tion thresholds, which provided a measure of temporal acuity, and
click-evoked potentials.
Furthermore, a commonly used behavioural test for tinnitus in
animals is known as gap-pre-pulse inhibition of the acoustic startle
(GPIAS; Turner et al., 2006; Turner & Parrish, 2008; Longenecker
& Galazyuk, 2011; Dehmel et al., 2012; Turner et al., 2012; Berger
et al., 2013; Chen et al., 2013; Coomber et al., 2014). This test
exploits a phenomenon whereby a response to a startling stimulus
can be inhibited by a preceding gap in otherwise continuous back-
ground noise. The original hypothesis for the test was that, if the
animal is experiencing tinnitus after a particular intervention (such
as salicylate administration), the gap will become less salient and
the startle response will not be inhibited as effectively. However,
two recent studies in humans have cast doubt on this interpretation
of behavioural gap detection deﬁcits (Campolo et al., 2013; Boyen
et al., 2015), as well as one study in rats (Radziwon et al., 2015)
and a review (Eggermont, 2013).
An important aspect of all the studies that have failed to ﬁnd a
difference in gap detection abilities in patients with tinnitus, as well
as in salicylate-administered rats, is that they determined either gap
detection thresholds or psychophysical gap detection abilities, rather
than inhibiting a startle response with a preceding gap. Moreover,
by employing a GPIAS paradigm, Fournier & Hebert (2013) were
able to demonstrate signiﬁcant deﬁcits in gap detection in tinnitus
patients, albeit at frequencies below their tinnitus. Indeed, work
from our own laboratory indicated that minimum gap detection
thresholds (MGDTs) in the inferior colliculus were slightly increased
following noise exposure, but not to an extent that could explain
behavioural gap detection deﬁcits that were present in the same ani-
mals (Berger et al., 2014).
Weible et al. (2014) recently demonstrated that they could affect
the degree of startle attenuation (as measured behaviourally) by
using optogenetics to alter inhibitory and excitatory activity in the
auditory cortices of mice, while preserving MGDTs. This therefore
implies that there may be disparate underlying mechanisms between
gap detection thresholds, which they suggested are a measure of
temporal acuity, and inhibition of a startle response by a preceding
gap, which they proposed as a measure of gap salience. To examine
these differences, in a separate group of GPs but with the same dose
of salicylate as used for measuring MGDTs, we recorded beha-
vioural GPIAS responses and awake neural responses to the same
stimuli as used in the behavioural test, in order to further explore
the potential mechanisms behind the GPIAS test. We hypothesized
that we would (i) show behavioural gap detection deﬁcits in GPs
administered salicylate, (ii) demonstrate MGDTs in auditory cortex
were not altered sufﬁciently to explain such behavioural deﬁcits fol-
lowing the same dose of salicylate, (iii) show for the ﬁrst time that
evoked responses in auditory cortex can be inhibited by a preceding
gap in otherwise continuous background noise [termed gap-induced
reductions of evoked responses (GIREP)], and (iv) ﬁnd deﬁcits in
GIREP following salicylate administration that corresponded to
behavioural deﬁcits in the same GPs.
Materials and methods
Animals
All procedures were carried out in accordance with the European
Communities Council Directive of 24 November 1986 (86/609/
EEC) and the approval of the Animal Welfare and Ethical Review
Body at the University of Nottingham, UK. Experiments were con-
ducted on a total of 13 tricolour GPs (ﬁve male and eight female)
weighing 500–800 g at the time of implantation.
ECoG array implantation
To record ECoG signals, a custom electrode array was ﬁrst pre-
pared. This consisted of eight uninsulated silver wires heated to pro-
duce a ball on the end in order to prevent damaging the dura mater
when implanted. These were soldered on to a circuit board attached
to a Tucker Davis Technologies (TDT, Alachua, FL, USA) zero
insertion force (ZIF)-clip connector.
During implantation, which was performed aseptically, GPs were
initially anaesthestized with ketamine (40 mg/kg, i.p.) and xylazine
(8 mg/kg, i.p.) and then artiﬁcially respired on an isoﬂurane/O2 mix-
ture throughout the procedure to maintain a constant state of areﬂex-
ia. Core body temperature was maintained at 38  0.5 °C using a
homeothermic heating pad (Harvard Apparatus Ltd., Edenbridge,
UK) and a rectal probe. The head was shaved and wiped with
iodine. Lidocaine injections were administered subcutaneously
around the area of incision. An incision was made along the midline
of the head, from ~ 4 mm in front of bregma to the nuchal ridge, as
well as small lateral incisions (~ 3 mm) at either end. Muscle and
connective tissue were cleared and small burr holes for electrode
placement were made in the locations described below. Two small
screws were inserted into the skull to act as anchoring points for the
electrode array.
A schematic of the electrode positions is shown in Fig. 1A. Indi-
vidual electrodes were placed into burr holes over rostral and caudal
AC on each side, while a further two were positioned over cerebel-
lum on each side in order to record ABRs. Reference and ground
electrodes were linked via a jumper on the electrode board and
implanted ~ 3 mm rostral to bregma, just off midline on either side.
Based on coordinates from Grimsley et al. (2012), the rostral and
caudal electrodes were putatively over the dorsorostral edge of pri-
mary AC (abbreviated to rostral) and the dorsocaudal area (abbrevi-
ated to caudal) respectively (see Fig. 1B).
After electrode insertion, burr holes and the underside of the elec-
trode board were ﬁrst covered with Kwik-Cast silicone sealant
(World Precision Instruments, Hitchin, UK) and then with dental
acrylic. The wound was sutured with Mersilk (Ethicon, Livingston,
UK) and covered in antibiotic cream. Cyanoacrylate was applied to
stick the skin around the board. GPs were removed from the isoﬂu-
rane and placed in a recovery box until they were stable enough to
return to their home cage. GPs were left for at least 24 h before
beginning baseline ABR and ECoG recording.
Recording setup
For chronic recording of ABR and ECoG signals, a custom-made
cage (30 9 15 9 21 cm) surrounded by acoustic foam was placed
inside a sound-attenuating chamber. An infrared webcam was placed
above the cage to monitor the animal’s movement. Animals were
not restrained and were allowed to move freely within the cage.
Auditory stimuli were presented free-ﬁeld via a single ¾-inch twe-
eter (Tymphany XT19TD00) positioned ~ 30 cm above the centre
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of the cage. Sound pressure level calibration was performed before
each recording session using custom-written Matlab scripts and two
¼-inch free-ﬁeld microphones (G.R.A.S. 26AC) placed at either end
of the cage.
During ABR and ECoG recording, a ZIF-clip digital headstage
was attached to the implanted electrode, and linked to the recording
computer via a TDT Medusa headstage ampliﬁer connected to a
TDT System 3 interface. Recordings were collected with lights
switched off in the chamber. Online data collection was facilitated
by either Brainware (software developed by J. Schnupp, University
of Oxford, UK) or custom-written Matlab scripts, depending on the
types of responses being recorded. Recorded ECoG signals were ﬁl-
tered online between 0.5–300 Hz for resting-state oscillatory activ-
ity, 100–5000 Hz for ABRs and 60–300 Hz for all other stimuli.
All data were analysed ofﬂine with custom-written Matlab scripts.
Salicylate and vehicle treatment
Following baseline data collection (see below), we administered
sodium salicylate (350 mg/kg; i.p.) dissolved in saline to awake
GPs and examined the effects on cortical ECoG activity 2 h later, as
well as on suprathreshold ABR responses, in eight of the 13 GPs.
This time-point was selected as previous studies have demonstrated
effects on behaviour and neural activity 2 h after salicylate (Guitton
et al., 2003; Ralli et al., 2010; Berger et al., 2013). We have also
previously demonstrated behavioural effects of salicylate at this dose
(Berger et al., 2013). Furthermore, in ﬁve of these eight GPs, vehi-
cle treatment consisting of saline without salicylate was performed
2 days prior to administering salicylate and all the electrophysiologi-
cal markers mentioned above were assessed, to determine whether
effects seen were simply caused by an intraperitoneal injection, as
opposed to direct effects of salicylate.
ABR stimuli and recording
ABRs were recorded from cerebellar electrodes using custom-written
Matlab scripts. Tones of ﬁve different frequencies between 5 and
20 kHz (70 dB SPL, 5 ms duration, 0.1 ms on/off ramp) were pre-
sented in a randomized order, the signal was presented with alternat-
ing polarity to allow cancellation of any stimulus artefact. A total of
500 repeats for each condition were presented during each session.
Ofﬂine, signal sweeps with an RMS greater than three absolute devi-
ations above the median were rejected from further analysis and the
rest of the data were averaged across repeats. Median absolute devia-
tion (MAD) was used for artefact rejection as it provides a more
robust measure of dispersion than standard deviation (Leys et al.,
2013). The peak-to-trough amplitude of the largest ABR response
was compared before and 2 h after salicylate administration. The lar-
gest ABR response was typically recorded as starting ~ 3 ms after
sound presentation. However, ~ 1.5 ms of this delay was accounted
for by the time for stimuli to travel the distance between the free-ﬁeld
speaker and the GP’s head. Therefore, the latency between sound
presentation at the GP’s ears and the start of the largest ABR
response prior to salicylate administration was ~ 1.5 ms, consistent
with wave I of the subcutaneously recorded ABR (e.g. Dehmel et al.,
2012). Preliminary data from three GPs, in which we recorded audi-
tory nerve compound action potentials from the round window of the
cochlea concurrently with the cerebellar signals, further suggested
that the largest deﬂection in the cerebellar electrode signals corre-
sponded to wave I of the subcutaneously recorded ABR, which is
indicative of auditory nerve activity.
Oscillations and click-evoked responses
Resting-state oscillatory activity and click-evoked responses were
recorded using Brainware before and after salicylate administration.
Data from four baseline sessions were averaged, with 100 repeats
recorded during each session. For resting-state activity, this com-
prised 10 s sweeps of recording in silence (1000 s total per ses-
sion). Data were analysed ofﬂine using custom-written Matlab
scripts. Artefact rejection involved including data only with an
RMS less than three absolute deviations above the median. Power
spectral analysis was performed on every 0.5 s sample of this
cleaned data set, resulting in an effective spectral smoothing of
2 Hz, and values were log-transformed in order to express power in
decibels (dB).
Neural activity was recorded in response to short clicks (50 ls),
with signals attenuated between 0–40 dB of full output (~ 100 dB
SPL RMS), in 10 dB steps, with an interstimulus interval (ISI) of
1500 ms. To compare between recordings during baseline and 2 h
after salicylate administration, peak-to-trough amplitudes were mea-
sured in the 50 ms following the stimulus.
Statistical analysis comparing baseline resting-state activity with
that recorded 2 h after salicylate administration was performed
using a cluster-based permutation test (Maris & Oostenveld, 2007).
This test allows for non-parametric testing of EEG signals and is a
A B
Fig. 1. (A) Illustration of GP head with silver-ball electrodes positioned over left and right rostral AC (1–2), caudal AC (3–4) and cerebellum (5–6), as well as
linked reference and ground electrodes (white and grey front circles). (B) Positioning of AC electrodes with respect to skull landmarks and the different areas
of the auditory cortex, based on a reconstruction from Grimsley et al. (2012).
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more sensitive measure than multiple t-tests with Bonferroni correc-
tions applied. For each frequency, a two-tailed, one sample t-test
was performed. All frequencies were selected for which their t-value
exceeded a pre-designated threshold (uncorrected P < 0.05), and
these were then clustered on the basis of spectral adjacency. t-
Values within each cluster were summed and this was used as the
cluster-level statistic. Subsequently, the maximum summed cluster
was used as a test statistic. Data for each GP were then randomized
across conditions (baseline/after salicylate) and this method was
repeated for all possible permutations of the data (n = 256). This
produced a distribution of maximum cluster t-values to which we
could reference the actual data, taking clusters which fell outside
the 95% conﬁdence interval of the distribution of t-values as
signiﬁcant.
Neural gap detection thresholds
Neural gap detection thresholds were determined using the method
described in Berger et al. (2014). Brieﬂy, auditory stimuli comprised
a broadband noise (BBN) burst (duration of 200 ms, on/off ramps
of 0.5 ms), followed by a ﬁxed-length period of silence or ‘gap’
(durations of either 1, 2, 4, 8, 10, 20, 50 or 75 ms) and a ﬁnal BBN
burst (duration of 50 ms, on/off ramps of 2 ms), all presented at
70 dB SPL. Each gap width condition was presented in ascending
order (50 repetitions, 1500 ms ISI). Responses were averaged across
repetitions, according to each condition. MGDTs were deﬁned as
the minimum gap duration where a signiﬁcant increase in activity
could be detected following the onset of the post-gap stimulus. A
signiﬁcant increase was conservatively determined as any peak
response > 5 standard deviations above the mean activity recorded
during a 50 ms window in the ﬁrst 200 ms.
Behavioural measure of gap detection ability
In a separate group of GPs (n = 5), both behavioural gap detection
abilities and neural responses to the same stimuli (GIREP) were mea-
sured. The behavioural method used to identify animals experiencing
tinnitus in this study is based on a gap detection paradigm devised by
Turner et al. (2006) in which we measured ﬂexion of the pinna, or the
Preyer reﬂex (Berger et al., 2013). The magnitude of the Preyer reﬂex
is calculated as pinna displacement under different acoustic condi-
tions, and these measurements are used to quantify gap-induced pre-
pulse inhibition (PPI) of the reﬂex. Following interventions that are
known to cause tinnitus, PPI is compromised. This method is
described elsewhere (Berger et al., 2013; Coomber et al., 2014).
Baseline behavioural testing
Baseline PPI of the Preyer reﬂex was measured in each GP over a
2-week period (minimum of three and a maximum of six testing ses-
sions). Startling stimuli (BBN bursts of 20 ms; rise/fall time of
1 ms) and continuous background noise conditions (either BBN or
2 kHz wide narrow-band noise centred at 5, 9, 13 or 17 kHz) were
used, as described previously (Berger et al., 2013, 2014; Coomber
et al., 2014). A gap duration of 50 ms was used to elicit gap-
induced PPI, consistent with that used by others (e.g. Turner et al.,
2006, 2012; Turner & Parrish, 2008). Sound levels for the beha-
vioural test were determined for each GP as described in our previ-
ous work. Brieﬂy, optimal sound levels of startling stimuli (95, 100,
or 105 dB SPL) and background carrier (55, 60 or 70 dB SPL) were
chosen to maximize baseline PPI for each animal (sound level-
dependency test; see Berger et al., 2013).
After baseline data collection, GPs that exhibited signiﬁcant PPI
in all background sound conditions were chronically implanted, their
behavioural gap detection ability was reassessed following recovery
and neural gap detection abilities determined, before administering
sodium salicylate and recording the same responses 2 h later. Oscil-
latory activity, click-evoked responses and MGDTs were not
recorded for these GPs due to time constraints.
Gap-induced reductions of evoked responses (GIREP)
The same stimuli used in the behavioural test were also presented
while recording neural activity, to allow for direct comparison of
behaviour and neural activity. This included using the same sound
levels and background frequencies, with the same number of repeti-
tions (10 gap/no-gap conditions for each frequency. Peak-to-trough
amplitudes of ECoG signals in the 50 ms following the startling
stimulus, averaged across repeats, were calculated for both no-gap
and gap conditions. In a similar manner to the behavioural test, a
percentage difference between ‘gap’ and ‘no-gap’ data were then
calculated and GIREP was expressed as a percentage decrease in
peak-to-trough amplitude when a gap was presented, compared with
the ‘no-gap’ condition. Data from all animals were pooled and the
effects of salicylate on the GIREP were assessed statistically for
each background noise condition with a two-way ANOVA and Bonfer-
roni post hoc test.
Results
ECoG data from the two sides were grouped prior to analysis, as
hemispheric differences were not expected as a result of an intraperi-
toneal injection and no clear differences were observed.
Changes in ABRs following salicylate
Suprathreshold (70 dB SPL) ABRs were recorded before and 2 h
after salicylate administration. A total of ﬁve different pure tone fre-
quencies, each one half an octave apart from the next, were tested:
5, 7.07, 10, 14.1 and 20 kHz. An example ABR from one GP
before and after salicylate administration is shown in Fig. 2B (inset).
Figure 2A shows the peak-to-trough amplitudes of the largest wave
(wave I) from the cerebellar electrodes before and after salicylate
administration for the ﬁve different frequencies, averaged across
GPs. Overall, there was a signiﬁcant effect of treatment on ABR
amplitudes for both the left ear (F1,19 = 11.78, P = 0.0028) and the
right ear (F1,20 = 17.90, P = 0.0004), as identiﬁed using a two-way
repeated measures ANOVA. Bonferroni post hoc analysis revealed that
there was a signiﬁcant reduction in amplitude at 20 kHz following
salicylate administration (left ear: t = 3.805, P < 0.01; right ear:
t = 3.605, P < 0.01). This indicates that there was reduced sensitiv-
ity in suprathreshold hearing for both ears at this frequency. The
amplitudes of the responses at all other frequencies measured were
slightly reduced, but did not reach statistical signiﬁcance.
Furthermore, there was also a signiﬁcant increase in wave I P1
latency at 20 kHz for left and right ears across GPs (left ear:
t = 4.153, P < 0.01, right ear: t = 3.678, P < 0.01), with mean
increases [ standard error of the mean (SEM)] of 0.13 ms
( 0.04 ms) and 0.12 ms ( 0.03 ms) respectively. Signiﬁcant
increases in latency were also evident for N1 of the wave I (left ear:
t = 4.613, P < 0.01; right ear: t = 3.257, P < 0.01), with mean
increases ( SEM) of 0.16 ms ( 0.03 ms) and 0.12 ms
( 0.03 ms). There were no signiﬁcant changes in latency at any
other frequencies for P1 or N1 measured from either ears.
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Changes in oscillatory activity following salicylate
Fast Fourier transforms were applied to resting-state ECoG data col-
lected during silence to produce power spectra. Figure 3 shows the
mean power spectra for eight GPs, collected before and 2 h follow-
ing salicylate administration. Statistical signiﬁcance was identiﬁed
using the cluster-based permutation test, with an alpha level of
P < 0.05. There was a signiﬁcant reduction in power following sali-
cylate (compared to baseline) between 6–10 Hz on the caudal corti-
cal electrodes (Fig. 3B), while a signiﬁcant increase in power was
evident between 20–68 Hz on the rostral cortical electrodes
(Fig. 3A). However, an increase in power on the rostral electrodes
was also evident (Fig. 3C) 2 h following vehicle treatment at similar
frequencies (14–68 Hz), suggesting that this effect was a result of
the stress associated with the intraperitoneal injection rather than
with salicylate per se. An increase in power was also evident on the
caudal electrodes between 50–70 Hz following vehicle treatment
(Fig. 3D). In summary, the reduction in power between 6–10 Hz on
the caudal electrodes appeared to be the only effect on oscillatory
activity unique to salicylate administration.
Changes in click-evoked responses following salicylate
Figure 4A shows responses to short clicks (50 ls), averaged across
eight GPs and recorded with a signal attenuation of 0 dB SPL (ap-
proximately 100 dB SPL RMS) before and 2 h after salicylate
administration, as well as 2 h after vehicle administration. Clear
increases in click-evoked potentials were evident at all sound levels
2 h after salicylate administration for both rostral and caudal AC
(Fig. 4C, left and middle panels). Increases ranged from 75 to 106%
for rostral AC and 134–149% for caudal AC, depending on the
sound level presented. These increases were clear to the extent that
they were often apparent in a single recording sweep for each GP
(Fig. 4B). There were no clear changes in the amplitudes of click-
evoked responses on the ABR channels (Fig. 4C, right panel). Fur-
thermore, no clear differences in click-evoked potentials were
evident 2 h following vehicle administration when compared to
baseline recordings.
Neural gap detection thresholds
Example responses used to determine MGDTs are shown in Fig. 5.
MGDT results before and 2 h after salicylate administration for each
GP are shown in Table 1. On the rostral AC electrodes, the median
MGDT was 8 ms ( 1 MAD) during baseline recordings. Two
hours following salicylate, the median had increased to 15 ms
( 12.5 MAD), although there was variability in MGDTs; two GPs
actually improved in their MGDTs, two showed minor decreases in
threshold and four showed more extensive decreases. However, only
one GP of these four had an MGDT greater than 50 ms, the gap
duration used for the behavioural test. On the caudal AC electrodes,
the median MGDT was 4 ms ( 2 MAD) during baseline and then
increased to 8 ( 4 MAD) following salicylate. One GP showed a
reduction in MGDT, two showed no change, three had minor
increases in MGDTs and two had more extensive increases. Again,
there was only one GP that had an MGDT of greater than 50 ms
following salicylate; this was the same GP that had an MGDT of
75 ms on the rostral AC electrodes (GP3 in Table 1). These results
indicate that while there were some changes in MGDTs, gaps of
50 ms duration, the duration used in the behavioural test, were
detectable by the majority of GPs following salicylate
administration.
Responses to behavioural gap detection stimuli
In a separate group of GPs (n = 5), gap detection was measured
behaviourally using the method described in Berger et al. (2013).
These data are summarized in Fig. 6. A two-way repeated mea-
sures ANOVA with Bonferroni post hoc test was used to statistically
compare data for all GPs collected after salicylate administration
with baseline recordings. There was a signiﬁcant effect of treat-
ment on behavioural performance across GPs (F1,19 = 4.45,
Fig. 2. (A) Peak-to-trough amplitudes of wave I ABRs recorded from the cerebellar electrodes, for all 5 frequencies from left ear (left panel) and right ear (right panel).
Data averaged across GPs (n = 5) and shown for before vs. 2 h after salicylate (**P < 0.01). Error bars indicate SEM. B (inset): Example responses from the cerebellar
electrodes from one GP in response to 20 kHz tones, before vs. after salicylate administration. P1 and N1 of the largest wave (ABR wave I) are labelled. GPs, guinea pigs.
[Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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P = 0.0484), whereby gap-induced PPI was signiﬁcantly smaller
2 h after salicylate. Post hoc analysis revealed that this effect was
restricted to the BBN background carrier (t = 3.805, P < 0.01).
These data are consistent with the results from Berger et al. (2013)
also collected 2 h after salicylate administration. Furthermore,
behavioural startle response amplitudes across GPs to ‘no-gap’
stimuli were signiﬁcantly enhanced 2 h following salicylate
(P = 0.0002; Wilcoxon Signed-Rank test), from a mean of
4.98 mm ( 0.72 mm SEM) to 7.93 mm ( 0.95 mm SEM). This
was also consistent with our previous results following salicylate
administration.
The same stimuli used in the behavioural test were also presented
while recording ECoG from the same group of GPs that had been
behaviourally tested. Figure 7A shows example AC responses to a
BBN stimulus with and without a preceding gap in background
noise. Prior to salicylate administration, we were able to successfully
inhibit evoked potentials by presenting a gap prior to the startle-eli-
citing stimulus (GIREP), on both rostral and caudal AC electrodes
for all GPs (as in the example in Fig. 7A). Following salicylate
administration, there were frequency-speciﬁc deﬁcits in GIREP
across GPs on the rostral electrodes, an example of which is shown
in Fig. 7B. Overall, for the rostral AC electrodes (Fig. 7C), there
was a signiﬁcant effect of salicylate treatment on GIREP
(F1,19 = 22.62, P = 0.0001), a signiﬁcant difference between fre-
quencies (F4,19 = 4.28, P = 0.0123) and a signiﬁcant interaction
between the two factors (F4,19 = 6.08, P = 0.0025). This effect was
strongest for BBN, where there was a signiﬁcant deﬁcit in GIREP
(t = 5.554, P < 0.001), which was consistent with the BBN deﬁcit
observed in behavioural responses in the same GPs. A signiﬁcant,
but smaller deﬁcit was also evident in GIREP at 4–6 kHz
(t = 3.386, P < 0.05).
On the caudal AC electrodes (Fig. 7D), there was a signiﬁcant
effect of salicylate treatment overall (F1,19 = 14.75, P = 0.0011),
but no effect of frequency (F4,19 = 1.62, P = 0.2100) nor interaction
(F4,19 = 0.20, P = 0.9355), indicating that while there was a general
worsening in GIREP, this was not restricted to a particular fre-
quency on the caudal AC electrodes. Linear regression analysis
demonstrated that there was a signiﬁcant positive correlation
between the change in GIREP across electrodes and change in beha-
vioural PPI in the same GPs following salicylate (r2 = 0.10,
P < 0.05), that is, GPs with a greater deﬁcit in GIREP generally
exhibited a greater deﬁcit in behavioural PPI (Fig. 7E). There was
also a signiﬁcant positive correlation between GIREP and PPI in
general, indicating that a greater GIREP (gap/no-gap) ratio corre-
lated with a greater behavioural PPI ratio (gap/no-gap) in the same
GPs (r2 = 0.06, p < 0.05).
Fig. 3. Power spectra of resting-state activity from rostral AC (A) and caudal AC (B). Black lines and shading represent mean spectra ( SEM) of baseline
recordings across GPs (n = 8), while light grey lines and shading represent mean spectra ( SEM) of recordings 2 h after salicylate administration. Data are
also shown following vehicle administration (C and D). Dark shading between lines highlights signiﬁcant differences, determined using a cluster-based permuta-
tion test (Maris & Oostenveld, 2007). GPs, guinea pigs.
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In summary, the deﬁcits in GIREP observed in data recorded
from the rostral AC electrodes are aligned with those observed
behaviourally. We also analysed offset responses to gaps (gap ter-
mination responses) for the GIREP stimuli before and after salicy-
late, which were evident in response to BBN stimuli prior to the
startling stimulus (occurring in the 50 to 0 ms window in Fig. 7A
and B). Despite a signiﬁcant deﬁcit in GIREP in the rostral elec-
trodes for BBN, a two-tailed paired t-test indicated that there were
no signiﬁcant changes in the peak-to-trough amplitudes of gap ter-
mination responses to the same stimuli (t = 0.55, P = 0.61), high-
lighting that the deﬁcits in GIREP could not be explained by
deﬁcits in gap termination responses (Fig. 8). There were also no
deﬁcits in BBN gap termination responses for the caudal electrodes
(t = 0.65, P = 0.55).
Discussion
A variety of changes in neural activity in awake animals were
observed following salicylate administration. There were reductions
in peripheral hearing sensitivity, although large changes were
restricted to the highest frequency tested (20 kHz), changes in corti-
cal oscillations unique to salicylate, increases in cortical auditory
evoked potentials (despite reduced hearing sensitivity) and generally
minor changes in gap detection thresholds. Furthermore, to our
knowledge, this is the ﬁrst demonstration of gap-induced reductions
of auditory cortex evoked potentials in animals (as opposed to com-
monly examined gap termination responses), as well as the ﬁrst
study to demonstrate such deﬁcits following salicylate administra-
tion. This may be clinically relevant because it has been suggested
Fig. 4. Click-evoked potentials. (A) Mean responses across guinea pigs (GPs) ( SEM; n = 8) from rostral AC and caudal AC, recorded during baseline
(black), 2 h after vehicle (light grey) and 2 h after salicylate (dark grey). (B) An example trace of a single click-evoked response before vs. 2 h after salicylate.
(C) Mean peak-to-trough amplitudes of click-evoked responses across GPs ( SEM) for all attenuations recorded during baseline, 2 h after vehicle and 2 h after
salicylate from rostral AC (left panel), caudal AC (middle panel) and ABRs (right panel).
© 2016 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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that cortical recording of this sort might be the basis of an objective
test for tinnitus (Suh et al., 2013).
Cortical oscillatory activity is changed following sodium
salicylate administration
Signiﬁcant reductions in oscillatory power speciﬁc to salicylate
administration (as opposed to vehicle injection) were restricted to
the 6–10 Hz region on the caudal cortical electrodes, putatively over
the dorsocaudal area. These frequencies encompass the lower end of
alpha band oscillations, which have a bandwidth of 8–12 Hz and
play a role in inhibitory function (Klimesch, 2012). Several studies
have demonstrated reductions in alpha band activity power in
patients with noise-induced tinnitus (Weisz et al., 2005; Adamchic
et al., 2014; Schlee et al., 2014), although others have failed to ﬁnd
such changes (e.g. Ashton et al., 2007; Adjamian et al., 2012). Fur-
thermore, Weisz et al. (2005) and Adjamian et al. (2012) suggested
that increases in delta band activity may also be important in tinni-
tus generation, something which is not evident in our data.
Reductions in alpha activity form part of the basis for the idea of
thalamocortical dysrhythmia (Llinas et al., 1999; De Ridder et al.,
2015). Under this hypothesis, tinnitus is characterized by a reduction
in alpha activity in conjunction with an increase in gamma activity.
Our data do not fully support this idea being applicable to salicy-
late-induced tinnitus, however, as although we found an increase in
gamma activity in rostral AC, this was also evident following vehi-
cle treatment, whereas the reduction in 6–10 Hz activity was unique
to salicylate administration. This suggests that the change in gamma
may have been related to stress, which is known to be caused by IP
injections (Meijer et al., 2006). There is little published work on the
effects of stress on cortical oscillations in the auditory cortex
directly. However, acute stress is known to affect the intensity of
paradoxical sleep in rodents (Meerlo et al., 1997) and two periods
of paradoxical sleep occur on average every hour throughout the
day even in head-restrained GPs (Escudero & Vidal, 1996). Para-
doxical sleep is associated with increased gamma band oscillations
and these may have been picked up in our recordings. Furthermore,
fear conditioning enhances gamma band oscillatory activity in audi-
tory cortex (Headley & Weinberger, 2013). Although vehicle injec-
tions also increased gamma band activity, it is still possible that a
combination of reduced inhibitory alpha activity in the dorsocaudal
area and an increase in gamma band activity in primary AC could
contribute to the tinnitus percept.
It is generally assumed that high doses of salicylate reliably pro-
duce the symptom of tinnitus, but we did not behaviourally test the
Fig. 5. An example of how neural gap detection thresholds were deter-
mined. Gaps were considered detected if there was a signiﬁcant increase in
activity during presentation of the second 50 ms stimulus (indicated by the
black lines below the traces) compared to a 50 ms period during the ﬁrst
200 ms stimulus (indicated by the grey lines above the traces). Minimum
gap detection thresholds were deﬁned as the lowest gap duration that elicited
this difference.
Table 1. Minimum gap detection thresholds (MGDTs) (in ms) before vs.
2 h after salicylate for each individual GP, recorded from rostral AC and
caudal AC. Median MGDTs [ median absolute deviations (MAD)] are
shown at the bottom of each column
GP
Rostral Caudal
Before After Before After
1 8 50 4 8
2 8 10 8 50
3 8 75 8 75
4 10 50 4 4
5 4 20 2 8
6 8 4 4 1
7 4 1 8 8
8 2 4 2 4
Medians 8 15 4 8
MAD 1 12.5 2 4
Fig. 6. Behavioural gap-induced PPI data recorded for ﬁve different back-
ground frequencies before (black) and 2 h after (grey) salicylate administra-
tion. Data are shown as gap responses/no-gap responses and are averaged
across GPs (n = 5). A value of 1 would indicate that the gap was not
detected at all, whereas a value lower than one would suggest that the gap
was inhibiting the response. Error bars represent SEM (*P < 0.05). GPs,
guinea pigs; PPI, pre-pulse inhibition.
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same animals from which we recorded oscillatory ECoG activity.
However, we demonstrated tinnitus-like behavioural deﬁcits follow-
ing the same dose of salicylate in a separate group of GPs, consis-
tent with our previous study (Berger et al., 2013). Behavioural data
were collected 2 h after administration, as were ECoG data from
GPs where oscillatory activity was recorded, thereby suggesting that
the GPs that were not behaviourally tested would also have been
likely to have experienced tinnitus at this time-point. However,
differences in tinnitus induction (salicylate vs. noise exposure) could
explain inconsistencies with human studies, and further research is
required to determine changes in ECoG activity following noise
exposure that may relate to tinnitus.
Auditory evoked responses are increased despite reduced
peripheral sensitivity
There were clear enhancements in evoked responses at both rostral
and caudal cortical electrodes 2 h following salicylate. These were
present despite a reduction in the amplitude of wave I brainstem
responses to 20 kHz tones and no change in the cerebellar ABR to
clicks, indicating that high frequency auditory nerve activity was
reduced, likely due to the ototoxic effects of salicylate (see Cazals,
2000 for a review). These results are consistent with the effects of
salicylate shown previously (Sun et al., 2009; Fang et al., 2016)
and could suggest a compensatory mechanism in line with the cen-
tral gain theory of tinnitus (Schaette & Kempter, 2006; Schaette &
McAlpine, 2011), in which a reduction in peripheral sensitivity initi-
ates homeostatic mechanisms that increase central auditory activity.
Furthermore, increased evoked activity could be an indication of
hyperacusis, an oversensitivity to sound that is commonly comorbid
with tinnitus (Baguley, 2003). Indeed, we also observed enhanced
startle amplitudes following sodium salicylate, a behavioural mea-
sure which has previously been suggested as a correlate of hypera-
cusis (e.g. Chen et al., 2013). Direct effects of sodium salicylate on
the brain could be responsible for this sound-evoked enhancement
Fig. 7. Gap-induced reductions of evoked potentials (GIREP). (A,B) Example responses recorded from AC electrodes for 1 GP to a BBN startling stimulus
embedded in continuous background noise with no-gap preceding (light grey), compared to responses with a 50 ms gap preceding the startling stimulus (dark
grey) are shown before (A) and 2 h after (B) salicylate administration. (C, D) Mean ratios of gap responses/no-gap responses recorded from rostral AC (C) and
caudal AC (D) before and after salicylate administration for the same ﬁve frequencies as presented in the behavioural test. As with the behavioural data, a value
of 1 would indicate that the gap was not having an effect on evoked responses, whereas a value lower than one would suggest that the gap was inhibiting the
evoked response. Error bars indicate SEM (***P < 0.001; *P < 0.05). (E) Linear regression analysis for change in GIREP vs. change in behavioural PPI in the
same GPs following salicylate administration. A value of 1 would indicate no change in GIREP or behavioural PPI, whereas a lower value would suggest a def-
icit in either measure. GPs, guinea pigs; BBN, broadband noise; PPI, pre-pulse inhibition.
Fig. 8. Peak-to-trough amplitudes of gap termination responses for broad-
band noise gap-induced reductions of evoked potentials stimuli, occurring
prior to the startling stimulus, for rostral and caudal electrodes before vs.
after salicylate administration.
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European Journal of Neuroscience, 1–12
Salicylate-induced neural changes in awake animals 9
and may not parallel changes occurring following noise exposure
(Auerbach et al., 2014), although Norena et al. (2010) demonstrated
similar effects on evoked potentials for both noise exposure and
sodium salicylate in awake GPs. This therefore suggests that these
two tinnitus inducers may cause gain enhancement in a similar man-
ner, despite different timescales.
It is interesting that increased evoked activity was evident on both
the rostral and caudal electrodes following salicylate administration,
but that reductions in alpha band activity were only evident on the
caudal electrodes. This suggests that there may be different path-
ways involved in hyperacusis (increased evoked responses) com-
pared with tinnitus (changes in oscillatory activity evident in
silence). Indeed, disparate mechanisms between the two often co-
morbid phenomena have previously been suggested (Knipper et al.,
2013).
Alterations in gap detection ability following salicylate
administration
Deﬁcits in behavioural gap detection performance following either
salicylate administration or noise exposure are often taken as a cor-
relate of tinnitus in animals (Turner et al., 2006, 2012; Turner &
Parrish, 2008; Longenecker & Galazyuk, 2011; Dehmel et al., 2012;
Berger et al., 2013; Chen et al., 2013; Coomber et al., 2014),
although doubt has been cast as to the efﬁcacy of this model in
detecting tinnitus (Campolo et al., 2013; Fournier & Hebert, 2013;
Lobarinas et al., 2013). Here, we found that there were some
increases in neural gap detection thresholds (in response to BBN)
2 h following sodium salicylate administration. This was consistent
with the results of Berger et al. (2014) in the inferior colliculus fol-
lowing noise exposure, as well as Deng et al. (2010), who demon-
strated increases in auditory cortex MGDTs following salicylate
administration in rats. However, there was only one GP with mini-
mum neural gap detection thresholds of greater than 50 ms, thereby
suggesting that, for the majority of GPs, their temporal acuity was
not affected to an extent that they would no longer be able to per-
form the behavioural task. This was true also in the Deng et al.
(2010) study, where auditory cortex MGDTs were still far below
50 ms following salicylate.
Contrastingly, behavioural responses to a BBN background car-
rier were signiﬁcantly altered 2 h following sodium salicylate
administration (consistent with the results of Berger et al., 2013).
Interestingly, the same was true for neural responses to the beha-
vioural gap detection stimuli. When gap termination responses were
analysed to these same stimuli, which are usually used for determin-
ing MGDTs, there were no differences in amplitudes following sali-
cylate. These data suggest that there are separate mechanisms
behind the two different tasks; that is, the reduction of either
evoked neural responses to a startling stimulus in auditory cortex or
behavioural startle responses by a preceding gap may not directly
relate to absolute gap detection thresholds in auditory cortex. The
gap-induced PPI circuit has been attributed to the brainstem (Lowe
& Walton, 2015), but is thought to be subject to descending modu-
lation by structures such as the cortex and amygdala (Bosch & Sch-
mid, 2008). Thus, decorticate animals show impairments in GPIAS
for gaps of < 50 ms duration (Ison et al., 1991; Threlkeld et al.,
2008), suggesting that the cortex still plays a role in gap-induced
PPI at shorter gap durations. Interestingly, Weible et al. (2014)
found that suppressing cortical neural activity using optogenetics
following a gap could attenuate subsequent behavioural startle
responses for gaps with durations of ≤ 25 ms, but not for 50 ms
gaps (the duration used here), which further suggests that cortical
involvement is important only for shorter durations. Therefore, the
effect on gap-induced reductions of cortical evoked potentials that
we have observed here may simply be a reﬂection of processing
further down the auditory system. On the other hand, responses to
the neural gap detection threshold stimuli, whereby onset responses
to noise following a gap (i.e. offset responses to the gap or gap ter-
mination responses) are examined, may reﬂect processes occurring
above the level of the brainstem.
An alternative explanation is that the small changes in MGDTs
we observed following salicylate administration may have been
sufﬁcient to have caused signiﬁcant deﬁcits in behavioural gap
detection ability. Under this scenario, behavioural deﬁcits follow-
ing tinnitus induction would reﬂect impaired acuity, as opposed to
the original hypothesis of tinnitus ﬁlling the gap (Turner et al.,
2006).
Regardless of the mechanism underlying the disparity between
the two measures of gap detection ability, an important point regard-
ing the relationship between behavioural testing in animals and gap
detection in humans with tinnitus is highlighted. Namely, simply
showing that there are no clear differences in psychophysical gap
detection in humans with tinnitus (or animals for that matter), as
demonstrated by Campolo et al. (2013), Boyen et al. (2015) and
Radziwon et al. (2015), may not be sufﬁcient to tell us whether or
not the behavioural test can determine whether animals are experi-
encing tinnitus, It is likely more important to demonstrate deﬁcits in
gap-induced PPI of a startle response in humans to support the idea
that this test is a suitable objective test for tinnitus in animals. The
data above suggest that there are likely important differences
between gap-induced PPI of a reﬂex response and absolute gap
detection thresholds.
An important confound of the behavioural GPIAS test is that
interventions that are known to induce tinnitus may also cause
hearing loss. Lobarinas et al. (2013) demonstrated that simulating
hearing loss in animals can result in false positives in the GPIAS
test, as startle amplitudes are reduced (for a review of hearing loss
and the GPIAS test, see Galazyuk & Hebert, 2015). However,
although we found that hearing loss was present in GPs in this
study, startle amplitudes were in fact increased following salicylate
administration, consistent with the results of other studies (Sun
et al., 2009; Chen et al., 2013). Furthermore, the clearest deﬁcit in
behaviour was evident for BBN stimuli, and we found that there
were no clear changes in ABR amplitudes for BBN (click) stimuli.
Therefore, this confound should not have affected interpretation of
the data presented here, although this is nonetheless an important
consideration when attempting to induce tinnitus with noise expo-
sure, which may cause a signiﬁcant decrease in startle response
amplitudes.
Neural activity recorded here following salicylate administration
suggests that there are fundamental changes that could give rise to
the presence of tinnitus. Importantly, there is evidence that indicates
hyperacusis-like effects are present and measurable in animals –
namely, increases in evoked auditory potentials and increases in
startle response amplitudes. Hyperacusis is a common comorbidity
in patients with tinnitus, with one study suggesting that it is present
in up to 86% of cases (Anari et al., 1999). Despite this, it is an
often overlooked issue in research (Moller et al., 2015). Further
understanding the mechanisms that give rise to such a phenomenon
may elucidate changes that also underlie the presence of tinnitus.
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